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Abstract
Objectives: To explore views on high quality diabetes care based on an analysis of existing diversity in diabetes care programmes
and related quality indicators.
Methods: A review of systematic reviews was performed. Four databases (MEDLINE database of the National Library of Medicine,
COCHRANE database of Systematic Reviews, the Cumulative Index to Nursing and Allied Health Database-CINAHL and Pre-
Cinahl) were searched for English review articles published between November 1989 and December 2006. Methodological quality of
the articles was assessed. A standardized extraction form was used to assess features of diabetes care programmes and diabetes quality
indicators with special reference to those aspects that hinder the conceptualization of high quality diabetes care. Based on these
findings the relationship between diversity in diabetes care programmes and the conceptualization of high quality diabetes care was
further explored.
Results: Twenty-one systematic reviews met the inclusion criteria representing a total of 185 diabetes care programmes. Six elements
were identified to produce a picture of diversity in diabetes care programmes and hinder their standardization: 1) the variety and
relative absence of conceptual backgrounds in diabetes care programmes, 2) confusion over what is considered a constituent of a
diabetes care program and components of the implementation strategy, 3) large variety in type of diabetes care programmes, settings
and related goals, 4) a large number and variety in interventions and quality indicators used, 5) no conclusive evidence on
effectiveness, 6) no systematic results on costs.
Conclusions: There is large diversity in diabetes care programmes and related quality indicators. From this review and our analysis
on the mutual relationship between diversity in diabetes care programmes and the conceptualization of high quality diabetes care, we
conclude that no single conceptual framework used to date provides a comprehensive overview of attributes of high quality diabetes
care linked to quality indicators at the structure, process and outcome level. There is a need for a concerted action to develop a
standardized framework on high quality diabetes care that is complemented by a practical tool to provide guidance to the design,
implementation and evaluation of diabetes care programmes.
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Background
Diabetes mellitus is a chronic disease for which the
worldwide epidemic proportions are described at
multiple occasions stressing the significant burden
because of its morbidity, mortality and socio-economic
cost w1–8x. Improving diabetes care is a topic of
concern as evidence suggests there is still a wide
variation in care among individuals, with rates of
recommended care processes to be unacceptably low
w9–15x. In response to deficiencies in diabetes care,
and particularly after the St. Vincent Declaration w16x,
a large number of quality improvement programmes
have been launched in primary care, outpatient, hos-
pitals and community settings to improve care for
mainly adult type 2 diabetic patients. Most of these
programmes are considered ‘complex interventions’
because of their multifaceted approach to improve
quality of care w17–19x. Complex interventions are
characterized by a variety of interconnecting parts
which may act both independently and interdepen-
dently w20x. Common labels and concepts that are
used to define such programmes are integrated care
w21, 22x, disease management w23, 24x, case man-
agement w25, 26x, co-ordinated care w27x or managed
care w28x. Although these programmes often have
common goals, they largely vary in what elements are
put forward to be associated with high quality diabetes
care. Some aspects of diversity in integrated chronic
care programmes have previously been documented
by Ouwens and colleagues w29x. The authors highlight
the difficulty of comparing the clinical and cost-effec-
tiveness of the different programmes and stress that
only 15% of the effects reported are significant, result-
ing from mainly short-term evaluations. Mechanisms
that explain success or failure of the programmes
remain unclear and for some interventions even
unknown w30x. Some of the aforementioned difficulties
have been documented in systematic reviews that
highlight diversity in diabetes care programmes w31,
32x. There is, however, to our knowledge no review
that provides a comprehensive overview of elements
that produce a picture of diversity in diabetes care
programmes and quality indicators. This paper is an
attempt to provide such overview. In addition, we
provide an in-depth analysis how different views on
high quality diabetes care programmes and indicators
affect the conceptualization of high quality diabetes
care.
Methods
We reviewed the scientific literature to identify system-
atic reviews on diabetes care programmes conducted
in primary care, outpatient, community and hospital
settings. A review of systematic reviews was deliber-
ately chosen as a method for this review as it allowed
both the assessment of systematic reviews on ele-
ments that cause diversity in diabetes care pro-
grammes, as well as the individual programmes that
were included in the reviews.
A diabetes care program was defined according to
the definitions of the Disease Management Associa-
tion of America w33x and applied to diabetes care. A
diabetes care program is a system of coordinated
health care interventions and communications using a
systematic approach to diabetes care and in which
patients self-care efforts are significant w33x. A ‘sys-
tematic approach to care’ was further operationalized
using the classification scheme from Shojania and
colleagues w34x who defined eleven distinct categories
of quality improvement interventions adapted from the
Cochrane Effective Practice and Organization Of Care
(EPOC) group w35, 36x. These categories are: patient
education, promotion of self-management, clinician
education, audit and feed-back, case management,
team changes, electronic patient registry, clinician
reminders, facilitated relay of clinical information to
clinicians, patient reminder systems and continuous
quality improvement.
Data sources
Four databases (MEDLINE database of the National
Library of Medicine, COCHRANE database of System-
atic Reviews, the Cumulative Index to Nursing and
Allied Health Database-CINAHL and Pre-Cinahl) were
searched for English articles published between
November 1989 and December 2006. This period was
chosen since most diabetes care programmes were
developed and implemented after the St. Vincent
Declaration of October 1989. The following free text
and (combinations of) Medical Subject Headings
(MeSH) were used: primary health care, ambulatory
care, hospitals, disease management, continuity of
patient care, comprehensive health care, case man-
agement, patient care team, patient care planning,
guidelines, practice guidelines, critical pathways, deliv-
ery of health care, delivery of integrated health care,
managed care programmes, quality of health care.
Furthermore, the terms shared care, coordinated care,
disease management, integrated care in combination
with diabetes mellitus were searched for as title andy
or abstract words. A hand search of bibliographies
from relevant reviews was also conducted.
Study selection
Two review authors (L.B., G.G.) independently
assessed articles for eligibility, extracted data andInternational Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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Box 1. QUORUM statement flow diagram: selection and inclusion of studies in the review.
assessed study quality. Disagreements about eligibil-
ity, extracted data and quality were resolved by con-
sensus between these authors. Where discrepancies
remained, the paper was reviewed by a third author
(J.H.). Titles were rejected if they did not deal with
adult patients with type 1 or type 2 diabetes or were
case reports, editorials, letters and duplicate entries.
Abstracts were rejected if they were not systematic
reviews. Studies were rejected if they did not report
on a systematic approach to care that evaluated
structural andyor organizational aspects andyor out-
comes of diabetes care. Reviews on risk reduction
programmes, screening programmes and rehabilita-
tion programmes were excluded from the review since
they do not encompass the whole continuum of care.
The selection and inclusion of the studies is presented
in Box 1 (QUORUM statement flow diagram).
Data extraction
To assess elements of diversity in diabetes care
programmes a standardized extraction form (see
Table 3) was created based on three items used in
the systematic review on integrated care programmes
by Ouwens and colleagues w29x. These authors have
documented in a review of systematic reviews impor-
tant diversity in integrated chronic care programmes
using four items. These items are: the use of concep-
tual backgrounds, goals, (cost) effectiveness and
‘requirements or operational needs for successful
implementation’. The latter item was not selected in
our review since theoretical components that consti-
tute a diabetes care programme became in this anal-
ysis distinguished from components that are part of
an implementation strategy. We added four other
items to the list that we considered important to assess
diversity in diabetes care programmes and quality
indicators. These items were: type of diabetes care
programmes, setting of care, type and number of
distinct interventions and type and number of indica-
tors. For an overview of definitions of these different
elements see Table 1. The different care programmes
were classified in seven distinct categories according
to the type of interventions they represented. These
categories were educational programmes, profession-
al and organizational programmes and respective
combinations w37x.
Methodological quality of systematic
reviews
Methodological quality of the reviews was assessed
using the QUORUM (Quality Of Reporting Of Meta-
analyses) statement checklist w44x. The checklist
describes the preferred way to present the abstract,
introduction, methods, results and discussion sections
of systematic reviewsymeta-analysis. It is organized
into 20 headings and subheadings regarding search-
es, selection, validity assessment, data abstraction,
study characteristics, quantitative data synthesis and
trial flow. A summary of the extraction is presented in
Table 2.
Results
Description of systematic reviews
The initial search identified a total of 2,858 citations,
published between November 1989 and DecemberInternational Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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Table 2. QUORUM statement checklist: summary of items reported in 21 reviews (YesyNoyNot aplicable)
Systematic reviews Title Abstract Introduction Methods Results Discussion
Greenhalgh, 1994 w45x YN Y N N N
Griffin et al., 1998 w46x YY Y Y Y Y
Renders et al., 2001 w32x YY Y Y Y Y
Norris et al., 2002 w38x YY Y Y Y Y
Norris et al., 2002 w47x YY Y Y Y Y
Sarkisian et al., 2003 w48x YY Y Y Y Y
Gary et al., 2003 w49x YY Y Y Y Y
Loveman et al., 2003 w50x YY Y Y Y Y
Warsi et al., 2004 w51x YY Y Y Y Y
Ellis et al., 2004 w52x YY Y Y Y Y
Ofman et al., 2004 w53x YY Y Y Y Y
Vermeire et al., 2005 w54x YY Y Y Y Y
Deakin et al., 2005 w55x YY Y Y Y Y
Murray et al., 2005 w56x YY Y Y Y Y
Ouwens et al., 2005 w29x YY Y N A N A Y Y
Knight et al., 2005 w57x YY Y Y Y Y
Bowker et al., 2005 w58x YY Y Y Y Y
Shojania et al., 2006 w34x YY Y Y Y Y
Glazier et al., 2006 w59x YY Y Y Y Y
Steuten et al., 2006 w39x YY Y Y Y Y
Lindenmeyer et al., 2006 w60x YY Y Y Y Y
Table 3. Elements of diversity evaluated in 21 systematic reviews on diabetes care programmes
Studies Conceptual Type of Goals Setting Interventions Indicators Effectiveness Costsy
back- program (Typey (Typey Economic
ground number) number) outcomes
Greenhalgh, 1994 w45x XX
Griffin et al., 1998 w46x XX XX
Renders et al., 2001 w32x XX X X X
Norris et al., 2002 w38x XX X
Norris et al., 2002 w47x XX X
Sarkisian et al., 2003 w48x XX X X X
Gary et al., 2003 w49x XX X X X
Loveman et al., 2003 w50x XX X X
Warsi et al., 2004 w51x XX X X
Ellis et al., 2004 w52x XX X
Ofman et al., 2004 w53x XX X
Vermeire et al., 2005 w54x XX XX
Deakin et al., 2005 w55x XX X X X X
Murray et al., 2005 w56x XX X X
Ouwens et al., 2005 w29x XX X X X X
Knight et al., 2005 w57x XX X X
Bowker et al., 2005 w58x XX XX
Shojania et al., 2006 w34x XX X X
Glazier et al., 2006 w59x XX X X
Steuten et al., 2006 w39x XX X X X X
Lindenmeyer et al., 2006 w60x XX X X X
2006 (Medline database 2,664 hits, Cochrane Data-
base 127 hits and Cinahl and Pre-Cinahl basic 67
hits). After scanning titles of the citations and
abstracts, 28 were accepted for further screening and
full text articles were retrieved. After examination of
full text articles, 21 systematic reviews were included
in the review. Seven reviews were excluded since
they did not report on a systematic approach to care
or were risk reduction, screening or rehabilitation
programmes. Ten studies were systematic reviews
with a meta-analysis w32, 34, 38, 46, 47, 49, 51, 52,
55–57x and ten were systematic reviews without a
meta-analysis w32, 39, 45, 48, 50, 53, 54, 58–60x.
One review was a review of systematic reviews w29x.
Elements of diversity in diabetes care
programmes
Both the 21 systematic reviews (for an overview see
Table 3) as well as the total of 185 individual diabetes
care programmes represented in the reviews wereInternational Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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assessed on the features they represented. An over-
view of all 185 diabetes care programmes and a
reference list are available upon request or can be
downloaded from http:yywww.diabetesproject.be.
Conceptual backgrounds in diabetes care
programmes
Only four of the systematic reviews explicitly analyzed
the use of conceptual backgrounds in diabetes care
programmes. Some reviews used the conceptual
frameworks of disease andyor case management to
classify diabetes care programmes under review w38,
39, 57x. Of all individual diabetes care programmes
only 5% (ns9) were theory based. Disease and case
management are the frameworks most commonly
used in diabetes care programmes. The Chronic Care
Framework of Wagner and colleagues w61x was used
in only three studies. The Innovative Care for Chronic
Conditions Framework w62x as well as diabetes spe-
cific conceptual frameworks were not reported.
Goals and type of diabetes care programmes
Measurement of effectiveness was the goal most
commonly cited in diabetes care programmes with
only very few studies specifying other types of goals.
Diabetes care programmes that were classified in this
review as ‘educational’ were most prevalent (27%;
ns50), followed by combined ‘educational and organ-
izational’ care programmes (16%; ns29), ‘organiza-
tional’ programmes (14%; ns26), ‘professional’
programmes (14%; ns25), combined ‘educational
and professional’ programmes (12%; ns23), ‘educa-
tional, professional and organizational’ programmes
(12%; ns23) and ‘professional and organizational’
programmes (5%; ns9).
Setting of diabetes care programmes
The settings in which most programmes occurred
were primary care andyor community facilities (47%;
ns87), with primary care physician offices to be most
prevalent. Other settings included hospitals (28%;
ns52), either academic or general, and hospital-
based diabetes or endocrinology units. Especially
U.S.-based programmes were conducted in outpatient
facilities (16%; ns29), HMOs (8%; ns15) and clinical
pharmacies (1%; ns2). Most of the programmes were
conducted in the U.S. (57%; ns105), Europe (28%;
ns52), Australia (5%; ns9), Canada (3%; ns5) and
other countries including Israel, Korea, Taiwan, Cuba,
New Zealand, Argentina, Hawaii and South Africa
(7%; ns14), reflecting different health care systems
and policies.
Interventions in diabetes care programmes
Interventions varied substantially across studies and
no study reported on more than four intervention arms.
The different reviews revealed the use of one to eight
quality improvement interventions that defined a dia-
betes care programme. Forty-five percent (ns83)
indicated the use of one quality improvement strategy,
18% (ns33) two strategies, 19% (ns35) three strat-
egies, 11% (ns20) four strategies and 7% (ns14)
five strategies or more. When only one intervention
was described this was often referred to as shared
care, team changes, facilitated relay, clinician educa-
tion and case management which in their turn reflect
multiple intervention strategies.
Next a description is given of the interventions found
in the reviews according to the eleven categories of
the Cochrane Effective Practice and Organization Of
Care (EPOC) group.
● Patient educationypromotion of self-manage-
ment Patient education andyor promotion of self-
management were present in 60% (ns111) of the
diabetes care programmes, although many modes
of instruction and interventionists were reported.
Interventions comprised didactic teaching methods
(individual patient counselling andyor group coun-
selling), didactic goal setting, goal setting negoti-
ated teaching method, situational problem solving,
cognitive reframing interventions or teaching meth-
ods such as telephone outreach andyor the provi-
sion of equipment (e.g., home glucometers),
printed and electronic educational materials or
access to resources (e.g., system for electronically
transmitting home glucose measurements and
receiving insulin dose changes based on data).
Interventionists reported were nurses, dieticians,
physicians, community workers, psychologists and
health educators with nurse educators to be the
most common interventionists to provide patient
education. Education provided by clinicians is less
prevalent in diabetes care programmes.
● Patient reminder systems Patient reminder sys-
tems were present in 16% (ns30) of the diabetes
care programmes, sometimes in combination with
clinician reminder systems. They included any
effort (e.g., telephone calls) to remind patients
about upcoming appointments or important aspects
of self-care.
● Clinician education Clinician education was pres-
ent in 29% (ns54) of the diabetes care pro-
grammes. These interventions comprised the
promotion of an increased understanding of prin-
ciples guiding clinical care or awareness of specific
recommendations for a target condition or patient
population. Subcategories of clinician education
included distribution of educational materials,
educational outreach visits and conferences or
workshops.International Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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● Clinician reminders Clinician reminders were
present in 16% (ns30) of the diabetes care pro-
grammes, sometimes in combination with patient
reminder systems. These interventions referred to
paper-based or electronic systems intended to
prompt a health professional (mostly physicians)
to recall patient-specific information (e.g., most
recent HbA1c value) or to perform a specific task
(e.g., perform a foot examination).
● Team changes About one-third of the programmes
(33%; ns61) included changes to the structure or
organization of the primary health care team. These
changes encompassed 1) the expansion or revi-
sion of professional roles (e.g., nurse or pharma-
cists play a more active role in patient monitoring
or adjusting medication regimens),2 ) adding a
team member or ‘shared care’ (e.g., routine visits
with personnel other than the primary care physi-
cian) or 3) the use of multidisciplinary teams in the
primary ongoing management of patients.
● Case management Case management was pres-
ent in 12% (ns22) of the diabetes care pro-
grammes. This intervention referred to any system
for coordinating diagnosis, treatment or ongoing
patient management by a person or a multidiscipli-
nary team in collaboration with or supplementary
to the primary care physicians.
● Facilitated relay of clinical information to clini-
cians Facilitated relay of clinical information to
clinicians was present in 7% (ns13) of the diabe-
tes care programmes. This type of intervention
referred to clinical information collected from
patients and transmitted to clinicians by means
other than the existing medical record. Examples
included electronic or Web-based tools through
which patients provided self-care data and which
clinicians reviewed, as well as point-of-care testing
supplying clinicians with immediate HbA1c values.
● Audit andyor feed-back Audit andyor feed-back
interventions were present in 7% (ns13) of the
diabetes care programmes. These interventions
included summaries of clinical performance of
health care delivered by an individual clinician or
clinic over a specified period, which were transmit-
ted back to the clinician (e.g., the percentage of a
clinician’s patients who achieved a target glycosy-
lated hemoglobin (HbA1c) level.
● Electronic patient registriesychanges in elec-
tronic medical records The use of electronic
patient registries andyor changes in electronic
medical records was present in 7% (ns13) of the
diabetes care programmes. Electronic patient reg-
istries referred to an electronic tracking system for
patients with diabetes.
● Systems for continuous quality improvement
Systems for continuous quality improvement were
reported in only three studies. These interventions
were described as either techniques of continuous
quality improvement, total quality management or
any iterative process for assessing quality prob-
lems, developing solutions to those problems, test-
ing their impacts, and then reassessing the need
for further action.
Our review demonstrates that no systematic review
on diabetes care program provides conclusive evi-
dence on what kind and how many interventions
should be included in a diabetes care program to
ensure improvements in quality of care, irrespective
of the initiator (HMO, MCO, Diabetes Care Center,
community clinics, insurance company) the setting
(primary care, outpatient, hospital and community
settings) or the co-ordinating caregiver (general
practitioner, nurse educator, internist, diabetologist
or pharmacist) of the program. Another important
observation is that very few systematic reviews
reveal information when to implement or how to
adapt the quality improvement interventions in
accordance to the individual needs and prefer-
ences, ethnicity, educational level and the stage
and the severity of the disease. Only one system-
atic review w59x reported on (features of) quality
improvement interventions for socially disadvan-
taged populations and elderly people.
Indicators in diabetes care programmes
In diabetes care programmes, a large variety of indi-
cators, definitions, classification schemes and meas-
urements are used. The different reviews revealed
the use from one to twelve quality indicators. Two
types of broad classification schemes are reported. A
first type of ‘patient indicators’ includes glycemic
control, microvascular and macrovascular outcomes,
resource utilization, provider-reported counselling
and patient-reported self-care. Other classification
schemes are based on the Donabedian triangle of
structure (e.g., healthcare settings and resources),
process (e.g., annual eye examinations) outcome
(e.g., hospitalization rate) w63x. In this, structural indi-
cators are defined as the physical and organizational
properties of the settings in which the care is provided.
Process indicators refer to all that is done for a
population of patients including preventive services
and measures, diagnosis and treatment. Outcome
indicators are the end results of care, that is, the
changes in patient or population health status, life
expectancy, quality of life and health care costs w39x.
Only one study reported on structural indicators refer-
ring to access and continuity of care. A combination
of outcome and process indicators was measured in
only 14% (ns26) of the studies. Most diabetes care
programmes adopt a glucocentric view of type 2International Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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diabetes, favoring glycemic control over indicators of
micro- and macro-vascular management or cardiovas-
cular outcomes. The most common glycemic indica-
tors cited in the diabetes care programmes were
HbA1c levels and fasting plasma glucose (FPG).
Glycemic control as a process measure and outcome
measure was measured in 19% (ns35) and 80%
(ns148) of the studies, respectively. Indicators of
micro- and macro-vascular management were meas-
ured in only 19% (ns35) of the studies. Provider-
reported counselling indicators as those pertaining to
foot care, self-monitoring of blood glucose and smok-
ing cessation get very little attention in diabetes care
programmes compared to indicators of glycemic con-
trol. Other provider related indicators such as satisfac-
tion were reported in only two studies. Patient-reported
or humanistic outcome indicators such as self-care
behaviors, generic and diabetes-specific health related
quality of life, satisfaction and psycho-social status
(e.g., self-efficacy, anxiety, onset distress and depres-
sion) were identified in, respectively, 11% (ns20),
7% (ns13),4 %(ns7) and 6% (ns11) of the dia-
betes care programmes.
It must be noted that diabetes self-management is
often an imprecisely defined term that captured activ-
ities including patient education for diabetes compli-
cations and management (e.g., foot care and self
monitoring of blood glucose), alcohol, food intake and
exercise advice and lifestyle visits w34x. Patient knowl-
edge with regard to, e.g., footcare and other treatment
modalities was measured in 13% (ns24) of the
diabetes care programmes.
Preference-based generic health related quality of life
indices such as the Health Utilities Index or Quality of
Well-Being Scale are not reported. Health economic
or resource utilization outcome indicators including
diabetes-related and health-care practitioner visits,
hospitalizations and emergency department visits and
were measured in, respectively, 5% (ns9),3 %(ns5)
and 1% (ns2) of the diabetes care programmes. No
single care program reported on absenteeism from
work. Indicators referring to costs were measured in
only three of the programmes. Least measured are
the extent of effective communication and patient-
centered reasoning and attitudes w58x. An overall
finding is that the indicators used in diabetes care
programmes are operationalized with different and
often not validated measurement instruments w64x.A
last element found is that there is often no link
between aims of the diabetes care programmes and
evaluated structure, process and outcome indicators
in a substantial part of studies on diabetes care
programmes, especially when efficiency of care is
concerned w39x.
(Cost) effectiveness of diabetes care
programmes
Systematic reviews that measure the effectiveness of
mainly disease and case management programmes
reveal modest but clinically and statistically significant
improvements in HbA1c and provider compliance
(annual monitoring of HbA1c, retinopathy screening,
screening for foot lesions and peripheral neuropathy,
lipid concentrations and proteinuria), but no improve-
ments in hospitalization rates and duration of stay,
patient satisfaction, patient knowledge, weight, body
mass index, blood pressure, lipid concentrations nor
compliance w34, 38, 57x. Improvements in HbA1c
show on average a net decrease of –0.5% (interquar-
tile range, –1.35% to 0.1%) w38x, with only a few
studies specifying what is considered an important
clinical improvement over time w34x. No systematic
review reported on the effectiveness of diabetes care
programmes on long-term health and quality of life
outcomes, including cardiovascular disease events,
renal failure, amputations, visual impairment and mor-
tality. Only three individual diabetes care programmes
reported on mortality rates and one on the number of
amputations after intervention.
The potential benefit of either nursing w34, 50x or
pharmacist-led w60x interventions in diabetes care pro-
grammes was evaluated in only three systematic
reviews. Not the professional background as such of
the nurse or pharmacist case managers seemed to
be important, but the possibility to make at least some
independent medication changes was associated with
positive effects on HbA1c w34x. In programmes that
focused on the effectiveness of pharmacist-led inte-
grated management and education programmes,
important improvements in HbA1c and hypoglycemic
episodes were noted. Positive effects on HbA1c were
also found if algorithm-based diabetes management
was applied by pharmacists. The potential benefit of
other professionals including primary care physicians,
diabetologists, internists and dieticians are not evalu-
ated in a systematic way.
The costs of diabetes care programmes are not
reviewed in a systematic way w29x and studies yield
conflicting and limited evidence around the cost-effec-
tiveness of diabetes care programmes. Other benefi-
cial effects of diabetes care programmes on how the
approach and infrastructure (e.g., practice guidelines,
information systems and resources) could be used for
the care of people with other chronic diseases has
not yet been evaluated in systematic reviews either.
Discussion
This review of systematic reviews is to our knowledge
the first to provide a comprehensive overview ofInternational Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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elements that create a picture of diversity in diabetes
care programmes and quality indicators. We recog-
nize, however, the methodological limitations to our
review. First, we have not searched for systematic
reviews on diabetes care programmes in every avail-
able database. Second, as we solely focused on
systematic reviews and the articles they represented,
we recognize there is a risk for publication bias. In
addition, our review has demonstrated that critical
appraisal of complex interventions remains difficult
with limited conclusive evidence to build on. The latter
is in line with findings from Lenz and colleagues w31x,
who published a methodological review of systematic
reviews and found that reviews do not meet the
challenge to sufficiently disclose the ‘active ingredi-
ents’ w20x of complex interventions in diabetes care.
A major finding from our review is the extent of
diversity in diabetes care programmes that conse-
quently highlight different views on high quality dia-
betes care. For this reason we argue the need to
develop a standardized framework on high quality
diabetes care. In this context, ‘standardization’ does
not imply the use of a rigid definition in what is
considered high quality diabetes care. We must at any
time recognize the import differences of the health
care settings in which diabetes care programmes are
conducted, as well as the cultural and socio-economic
characteristics and preferences of the different target
populations and providers. Before any attempt on the
standardization of the concept of high quality diabetes
care can take place, a profound insight is required on
how diversity in diabetes care programmes, quality
indicators and the conceptualization of high quality
diabetes care are mutually related. We consider three
elements to clarify this mutual relationship including;
1) the absence of a universally accepted definition on
high quality care, and diabetes care in particular,
2) limitations that characterize existing models and
frameworks on high quality (diabetes) care, and
3) poor understanding of how quality indicators at the
structure, process and outcome level in diabetes care
are mutually related. These elements will now be
discussed in more detail.
A first element to clarify the relationship is the absence
of a universally accepted definition on high quality
care, and diabetes care in particular. The large num-
ber of definitions used, either generic w65–67x or
disaggregated w68–72x demonstrate the complexity
and multidimensionality of the concept of quality. Our
review demonstrates that most studies consider effec-
tiveness and efficiency as key attributes to define the
concept of high quality diabetes care. Other attributes
of high quality diabetes care including acceptability,
accessibility, equity, solidarity, relevance, appropriate-
ness, respect, choice, safety and accessibility to infor-
mation w72–76x are less frequently used in diabetes
care programmes. Our review also demonstrates that
it is not clear from literature which interventions and
indicators in diabetes care programmes should be
used in relation to the aforementioned attributes. As
a consequence, depending on the definition used,
diabetes care programmes largely vary in the type
and number of interventions and quality indicators
used. In this context some authors argue the use of
at least three types of quality improvement interven-
tions to define ‘integrated’ care programmes, including
a patient-related intervention to support self-manage-
ment, a professional-directed intervention, and an
organizational intervention w29x. Although multifaceted
intervention strategies in diabetes care are considered
effective on outcomes of care w77–84x they largely
vary in the type and number of attributes of quality
care they represent, including effectiveness, efficien-
cy, acceptability, accessibility, equity, solidarity, rele-
vance and appropriateness of care.
A second element to clarify the mutual relationship
between diversity in diabetes care programmes and
the conceptualization of high quality diabetes care is
related to a number of limitations that characterize
existing models and frameworks on high quality,
chronic and diabetes care that provide a conceptual
basis to diabetes care programmes. As these frame-
works and models still present some important limita-
tions, diabetes care programmes that build on these
models present an important risk to reflect the same
limitations. The Chronic Care Model (CCM) w85x for
example, is a well known and highly valued conceptual
model that defines the concept of high quality chronic
care, and for which a related set of quality indicators
exists w77–85x. The author of the CCM states that
improvements in six interrelated components (com-
munity resources, self-management support, delivery
system redesign, decision support, clinical information
systems and organizational support) can produce sys-
tem reform that enhance patient–provider interactions
w77, 78, 80x. There is however, limited evidence to
support the validity of this model w26, 79, 86x and
additional studies seem to be necessary to determine
the association of CCM components with improved
outcomes w87x. Another limitation of the CCM is that
it has paid little attention to requirements for success-
ful implementation, although the CCM recognizes that
improvement in the care of patients with chronic illness
will only occur if system leaders make it a priority and
provide the leadership, incentives and resources nec-
essary to make improvements happen w88x. At this
stage, the type and number of attributes of quality
care used in the CCM provide an incomplete answer
to the conceptualization of high quality diabetes care.International Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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Only recently, improvements to the CCM have been
provided by the WHO through the development of the
Innovative Care for Chronic Conditions (ICCC) frame-
work w62x. Although this generic chronic disease mod-
el is certainly of use to define the constituents of high
quality diabetes care, it does not describe specific
changes that must be tailored to unique needs and
resources. Neither does it provide an overview of
quality indicators linked to structural, processes and
outcomes of care.
When we look at limitations of other, more recent
frameworks that focus on high quality chronic care
w39, 74x, we refer to frameworks that have explicitly
built on the Donabedian triangle of structure, process
and outcome w63x. These frameworks have used a
comparable number of attributes of quality care as
used in the CCM and the ICCC, but offer limited
practical guidance to the design and implementation
of diabetes care programmes.
In contrast to the CCM, ICCC and frameworks based
on the quality theory of Donabedian, the components
of disease management as defined by the Disease
Management Association of America (DMAA) w33x
have been used on a larger scale in diabetes care
programmes. There is, however, a diffuse picture of
what disease management really is, as it reflects
different forms of healthcare organization and delivery
w89x. Six components are considered in a ‘full service’
disease management program, including 1) population
identification processes, 2) evidence based practice
guidelines or performance standards of care, 3) col-
laborative practice models to include physicians and
support service providers, 4) patient self-management
education, 5) process and outcome measurement,
and 6) routine reporting andyor feed-back. Less com-
prehensive programmes include fewer components
and are considered ‘disease management support
services’.
An important limitation to the disease management
framework of the DMAA is that it lacks descriptive
detail on organizational, professional and patient-relat-
ed attributes of quality care, neither does it provide
guidance to determine what system changes or
actions that organizational teams must make in order
to improve outcomes of care w85x. This might be
explained as existing ‘full service’ disease manage-
ment programmes and research into their cost-effect-
iveness are still in their infancy w39x.
Another concept that is often used to provide a con-
ceptual basis to diabetes care programmes is case
management. Case management is considered the
assignment of authority to a professional, most com-
monly a nurse case manager, who oversees and is
responsible for coordinating and implementing care.
Case management has five essential features includ-
ing 1) identification of eligible patients, 2) assessment,
3) development of an individual care plan, 4) imple-
mentation of the individual care plan, and 5) monitor-
ing of outcomes w38x. Case management can be
implemented along with disease management, as a
single intervention or with other interventions.
Although substantial efforts have been made to refine
the concept of disease and case management w24x,
these concepts do not explicitly include important
attributes of high quality diabetes care that refer to
equity, accessibility or acceptability of care.
Finally, diabetes specific measures that exist for the
design and evaluation of quality care such as those
described in the Diabetes Quality Improvement Project
(DQIP 1.0 measure set) w90x focus on important
components of quality care as well, but the indicators
may not be detailed enough to fully evaluate specific
quality improvement interventions in the context of
controlled studies w64, 91x. Moreover, the latter indi-
cators do not provide guidance in health care systems
that strongly differ from US-based incentives for
patient and provider behaviors w58x.
A third and last element to clarify the mutual relation-
ship between diversity in diabetes care programmes
and the conceptualization of high quality diabetes is
the poor understanding of how quality indicators at
the structure, process and outcome level in diabetes
care are mutually related. This leads to a large varia-
bility in the use of indicators in diabetes care pro-
grammes and consequently has an important impact
on how high quality diabetes care is conceptualized.
To illustrate this finding we refer to the large number
of diabetes care programmes that favor process and
outcome indicators over structural and organizational
indicators of quality of care such as vision, leadership,
quality culture and (financial) incentives. The latter
indicators only recently get more attention w77, 92, 93x
as sparse but growing evidence suggests an important
relation between these indicators of quality care and
health and non health(economic) related outcomes in
patients and health care providers w93–99x. The same
issue is noted for patient-reported or humanistic out-
comes that are less frequently used compared to
clinical outcomes, despite literature suggesting these
variables to be valid and reliable in diabetes care
w100, 101x.
Conclusion
From our analysis on diversity in diabetes care pro-
grammes, quality indicators and the mutual relation-International Journal of Integrated Care – Vol. 8, 24 April 2008 – ISSN 1568-4156 – http://www.ijic.org/
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ship with the conceptualization of high quality diabetes
care, we conclude that no single conceptual frame-
work used to date provides a comprehensive overview
of attributes of high quality diabetes care linked to
qualityyperformance indicators at the structure, pro-
cess and outcome level. No framework at this stage
at the same time provides practical guidance to the
design, implementation and evaluation of diabetes
care programmes. We therefore argue the need for a
concerted action across healthcare systems to refine
the definition and concept of high quality diabetes care
and to develop a standardized framework on high
quality diabetes care. This framework must be flexible
and allow for context specific evaluations of diabetes
care programmes. The evidence offered by existing
conceptual models on high quality diabetes and chron-
ic care should serve as a theoretical basis to develop
the framework. The framework must allow broadening
of existing definitions and concepts of high quality
diabetes care beyond the attributes of effectiveness
and efficiency of care. The framework must also
highlight the mutual interdependencies of all relevant
diabetes quality indicators and allow for the develop-
ment of a new generation of diabetes care pro-
grammes that include a broad range of quality
indicators at the structure, process and outcome level
of care. It is of equal importance to complement the
framework by a practical tool that provides guidance
to researchers, change agents and organizational
teams to the implementation and evaluation of diabe-
tes care programmes. A last prerequisite of a frame-
work on high quality diabetes care is that it must
improve international comparability of the studies
and consequently provide an impetus to innovative
research in quality diabetes care.
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